MovDisordV3, PascalFrancis, Curation, bibRecord, 001B98

Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease

Identifieur interne : 001B98 ( PascalFrancis/Curation ); précédent : 001B97; suivant : 001B99

Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease

Auteurs : WON YONG LEE [Corée du Sud] ; WON TAE YOON [Corée du Sud] ; HEE YOUNG SHIN [Corée du Sud] ; SEONG HEE JEON [Corée du Sud] ; Poong-Lyul Rhee [Corée du Sud]

Source :

Movement disorders [ 0885-3185 ] ; 2008.

RBID : Pascal:08-0487367

Descripteurs français

Pascal (Inist)
- Infection, Maladie de Parkinson, Pathologie du système nerveux, Helicobacter pylori, Fluctuation, Homme, Lévodopa, Urées, Urée, Test respiratoire.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Breath test, Fluctuations, Helicobacter pylori, Human, Infection, Levodopa, Nervous system diseases, Parkinson disease, Urea, Ureas.

Abstract

To investigate whether Helicobacter pylori (HP) infection affects the clinical response to levodopa and whether its eradication could improve motor fluctuation in patients with Parkinson's disease (PD).Using the [¹³C] urea breath test, we monitored HP infection in 65 patients with PD and motor fluctuations of the "wearing-off" or delayed "on" types, with or without dyskinesia. We compared the clinical features and response to L-dopa between HP noninfected (n = 30) and HP infected patients (n = 35) by reviewing home diaries kept for 72 hours. Among HP infected patients, we compared the differences in L-dopa "onset" time, "on-time" duration, and scores on the motor examination section of the Unified PD Rating Scale (UPDRS-III) during the medication "on" phase before and after HP eradication. There were no differences in the age, disease duration, Hoehn and Yahr stage, UPDRS-III score, L-dopa daily dose, and frequency of dyskinesia between HP noninfected and HP infected groups. However, L-dopa "onset" time was longer and "on-time" duration was shorter in HP infected patients than in HP noninfected patients (78.4 ± 28.2 vs. 56.7 ± 25.1 and 210.0 ± 75.7 vs. 257.7 ± 68.9 min, respectively, P < 0.05). HP eradication improved the delay L-dopa "onset" time and short "on-time" duration (to 58.1 ± 25.6 and to 234.4 ± 66.5 min, respectively, P < 0.05). These data demonstrated that HP infection could interfere with the absorption of L-dopa and provoke motor fluctuations. HP eradication can improve the motor fluctuations of HP infected patients with PD.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 23`
A06				`@2 12`
A08	`01`	`1`	`ENG`	`@1 Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease`
A11	`01`	`1`		`@1 WON YONG LEE`
A11	`02`	`1`		`@1 WON TAE YOON`
A11	`03`	`1`		`@1 HEE YOUNG SHIN`
A11	`04`	`1`		`@1 SEONG HEE JEON`
A11	`05`	`1`		`@1 RHEE (Poong-Lyul)`
A14	`01`			`@1 Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine @2 Seoul @3 KOR @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut.`
A14	`02`			`@1 Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine @2 Seoul @3 KOR @Z 5 aut.`
A20				`@1 1696-1700`
A21				`@1 2008`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000196067980080`
A44				`@0 0000 @1 © 2008 INIST-CNRS. All rights reserved.`
A45				`@0 38 ref.`
A47	`01`	`1`		`@0 08-0487367`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 To investigate whether Helicobacter pylori (HP) infection affects the clinical response to levodopa and whether its eradication could improve motor fluctuation in patients with Parkinson's disease (PD).Using the [¹³C] urea breath test, we monitored HP infection in 65 patients with PD and motor fluctuations of the "wearing-off" or delayed "on" types, with or without dyskinesia. We compared the clinical features and response to L-dopa between HP noninfected (n = 30) and HP infected patients (n = 35) by reviewing home diaries kept for 72 hours. Among HP infected patients, we compared the differences in L-dopa "onset" time, "on-time" duration, and scores on the motor examination section of the Unified PD Rating Scale (UPDRS-III) during the medication "on" phase before and after HP eradication. There were no differences in the age, disease duration, Hoehn and Yahr stage, UPDRS-III score, L-dopa daily dose, and frequency of dyskinesia between HP noninfected and HP infected groups. However, L-dopa "onset" time was longer and "on-time" duration was shorter in HP infected patients than in HP noninfected patients (78.4 ± 28.2 vs. 56.7 ± 25.1 and 210.0 ± 75.7 vs. 257.7 ± 68.9 min, respectively, P < 0.05). HP eradication improved the delay L-dopa "onset" time and short "on-time" duration (to 58.1 ± 25.6 and to 234.4 ± 66.5 min, respectively, P < 0.05). These data demonstrated that HP infection could interfere with the absorption of L-dopa and provoke motor fluctuations. HP eradication can improve the motor fluctuations of HP infected patients with PD.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Infection @5 01`
C03	`01`	`X`	`ENG`	`@0 Infection @5 01`
C03	`01`	`X`	`SPA`	`@0 Infección @5 01`
C03	`02`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 02`
C03	`02`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 02`
C03	`02`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 02`
C03	`03`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 03`
C03	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 03`
C03	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 03`
C03	`04`	`X`	`FRE`	`@0 Helicobacter pylori @2 NS @5 09`
C03	`04`	`X`	`ENG`	`@0 Helicobacter pylori @2 NS @5 09`
C03	`04`	`X`	`SPA`	`@0 Helicobacter pylori @2 NS @5 09`
C03	`05`	`X`	`FRE`	`@0 Fluctuation @5 10`
C03	`05`	`X`	`ENG`	`@0 Fluctuations @5 10`
C03	`05`	`X`	`SPA`	`@0 Fluctuación @5 10`
C03	`06`	`X`	`FRE`	`@0 Homme @5 11`
C03	`06`	`X`	`ENG`	`@0 Human @5 11`
C03	`06`	`X`	`SPA`	`@0 Hombre @5 11`
C03	`07`	`X`	`FRE`	`@0 Lévodopa @2 NK @2 FR @5 12`
C03	`07`	`X`	`ENG`	`@0 Levodopa @2 NK @2 FR @5 12`
C03	`07`	`X`	`SPA`	`@0 Levodopa @2 NK @2 FR @5 12`
C03	`08`	`X`	`FRE`	`@0 Urées @5 13`
C03	`08`	`X`	`ENG`	`@0 Ureas @5 13`
C03	`08`	`X`	`SPA`	`@0 Ureas @5 13`
C03	`09`	`X`	`FRE`	`@0 Urée @2 NK @2 FR @5 14`
C03	`09`	`X`	`ENG`	`@0 Urea @2 NK @2 FR @5 14`
C03	`09`	`X`	`SPA`	`@0 Urea @2 NK @2 FR @5 14`
C03	`10`	`X`	`FRE`	`@0 Test respiratoire @5 15`
C03	`10`	`X`	`ENG`	`@0 Breath test @5 15`
C03	`10`	`X`	`SPA`	`@0 Test respiratorio @5 15`
C07	`01`	`X`	`FRE`	`@0 Spirillaceae @2 NS`
C07	`01`	`X`	`ENG`	`@0 Spirillaceae @2 NS`
C07	`01`	`X`	`SPA`	`@0 Spirillaceae @2 NS`
C07	`02`	`X`	`FRE`	`@0 Spirillales @2 NS`
C07	`02`	`X`	`ENG`	`@0 Spirillales @2 NS`
C07	`02`	`X`	`SPA`	`@0 Spirillales @2 NS`
C07	`03`	`X`	`FRE`	`@0 Bactérie`
C07	`03`	`X`	`ENG`	`@0 Bacteria`
C07	`03`	`X`	`SPA`	`@0 Bacteria`
C07	`04`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 37`
C07	`04`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`04`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`05`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 38`
C07	`05`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`05`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`06`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`06`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`06`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`07`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`07`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`07`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 316`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001121

Links to Exploration step

Pascal:08-0487367

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease</title>
<author><name sortKey="Won Yong Lee" sort="Won Yong Lee" uniqKey="Won Yong Lee" last="Won Yong Lee">WON YONG LEE</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
<author><name sortKey="Won Tae Yoon" sort="Won Tae Yoon" uniqKey="Won Tae Yoon" last="Won Tae Yoon">WON TAE YOON</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
<author><name sortKey="Hee Young Shin" sort="Hee Young Shin" uniqKey="Hee Young Shin" last="Hee Young Shin">HEE YOUNG SHIN</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
<author><name sortKey="Seong Hee Jeon" sort="Seong Hee Jeon" uniqKey="Seong Hee Jeon" last="Seong Hee Jeon">SEONG HEE JEON</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
<author><name sortKey="Rhee, Poong Lyul" sort="Rhee, Poong Lyul" uniqKey="Rhee P" first="Poong-Lyul" last="Rhee">Poong-Lyul Rhee</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0487367</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0487367 INIST</idno>
<idno type="RBID">Pascal:08-0487367</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001121</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001B98</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease</title>
<author><name sortKey="Won Yong Lee" sort="Won Yong Lee" uniqKey="Won Yong Lee" last="Won Yong Lee">WON YONG LEE</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
<author><name sortKey="Won Tae Yoon" sort="Won Tae Yoon" uniqKey="Won Tae Yoon" last="Won Tae Yoon">WON TAE YOON</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
<author><name sortKey="Hee Young Shin" sort="Hee Young Shin" uniqKey="Hee Young Shin" last="Hee Young Shin">HEE YOUNG SHIN</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
<author><name sortKey="Seong Hee Jeon" sort="Seong Hee Jeon" uniqKey="Seong Hee Jeon" last="Seong Hee Jeon">SEONG HEE JEON</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
<author><name sortKey="Rhee, Poong Lyul" sort="Rhee, Poong Lyul" uniqKey="Rhee P" first="Poong-Lyul" last="Rhee">Poong-Lyul Rhee</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Corée du Sud</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breath test</term>
<term>Fluctuations</term>
<term>Helicobacter pylori</term>
<term>Human</term>
<term>Infection</term>
<term>Levodopa</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Urea</term>
<term>Ureas</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Infection</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du   système nerveux</term>
<term>Helicobacter pylori</term>
<term>Fluctuation</term>
<term>Homme</term>
<term>Lévodopa</term>
<term>Urées</term>
<term>Urée</term>
<term>Test respiratoire</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To investigate whether Helicobacter pylori (HP) infection affects the clinical response to levodopa and whether its eradication could improve motor fluctuation in patients with Parkinson's disease (PD).Using the [<sup>13</sup>
C] urea breath test, we monitored HP infection in 65 patients with PD and motor fluctuations of the "wearing-off" or delayed "on" types, with or without dyskinesia. We compared the clinical features and response to L-dopa between HP noninfected (n = 30) and HP infected patients (n = 35) by reviewing home diaries kept for 72 hours. Among HP infected patients, we compared the differences in L-dopa "onset" time, "on-time" duration, and scores on the motor examination section of the Unified PD Rating Scale (UPDRS-III) during the medication "on" phase before and after HP eradication. There were no differences in the age, disease duration, Hoehn and Yahr stage, UPDRS-III score, L-dopa daily dose, and frequency of dyskinesia between HP noninfected and HP infected groups. However, L-dopa "onset" time was longer and "on-time" duration was shorter in HP infected patients than in HP noninfected patients (78.4 ± 28.2 vs. 56.7 ± 25.1 and 210.0 ± 75.7 vs. 257.7 ± 68.9 min, respectively, P < 0.05). HP eradication improved the delay L-dopa "onset" time and short "on-time" duration (to 58.1 ± 25.6 and to 234.4 ± 66.5 min, respectively, P < 0.05). These data demonstrated that HP infection could interfere with the absorption of L-dopa and provoke motor fluctuations. HP eradication can improve the motor fluctuations of HP infected patients with PD.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>23</s2>
</fA05>
<fA06><s2>12</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>WON YONG LEE</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>WON TAE YOON</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HEE YOUNG SHIN</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SEONG HEE JEON</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>RHEE (Poong-Lyul)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine</s1>
<s2>Seoul</s2>
<s3>KOR</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>1696-1700</s1>
</fA20>
<fA21><s1>2008</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000196067980080</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>08-0487367</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>To investigate whether Helicobacter pylori (HP) infection affects the clinical response to levodopa and whether its eradication could improve motor fluctuation in patients with Parkinson's disease (PD).Using the [<sup>13</sup>
C] urea breath test, we monitored HP infection in 65 patients with PD and motor fluctuations of the "wearing-off" or delayed "on" types, with or without dyskinesia. We compared the clinical features and response to L-dopa between HP noninfected (n = 30) and HP infected patients (n = 35) by reviewing home diaries kept for 72 hours. Among HP infected patients, we compared the differences in L-dopa "onset" time, "on-time" duration, and scores on the motor examination section of the Unified PD Rating Scale (UPDRS-III) during the medication "on" phase before and after HP eradication. There were no differences in the age, disease duration, Hoehn and Yahr stage, UPDRS-III score, L-dopa daily dose, and frequency of dyskinesia between HP noninfected and HP infected groups. However, L-dopa "onset" time was longer and "on-time" duration was shorter in HP infected patients than in HP noninfected patients (78.4 ± 28.2 vs. 56.7 ± 25.1 and 210.0 ± 75.7 vs. 257.7 ± 68.9 min, respectively, P < 0.05). HP eradication improved the delay L-dopa "onset" time and short "on-time" duration (to 58.1 ± 25.6 and to 234.4 ± 66.5 min, respectively, P < 0.05). These data demonstrated that HP infection could interfere with the absorption of L-dopa and provoke motor fluctuations. HP eradication can improve the motor fluctuations of HP infected patients with PD.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Infection</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Infection</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Infección</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Helicobacter pylori</s0>
<s2>NS</s2>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Helicobacter pylori</s0>
<s2>NS</s2>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Helicobacter pylori</s0>
<s2>NS</s2>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Fluctuation</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Fluctuations</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Fluctuación</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Human</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Lévodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Levodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Levodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Urées</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Ureas</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Ureas</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Urée</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Urea</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Urea</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Test respiratoire</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Breath test</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Test respiratorio</s0>
<s5>15</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Spirillaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Spirillaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Spirillaceae</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Spirillales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Spirillales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Spirillales</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Bactérie</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Bacteria</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Bacteria</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>316</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B98 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001B98 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:08-0487367
   |texte=   Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease

Helicobacter Pylori Infection and Motor Fluctuations in Patients with Parkinson's Disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri